Ou Medicine, Inc.

Audits
2
Findings
8
Total Expended
$77.05M
Latest Accepted
2024-03-21
Location: Oklahoma City, OK
UEI: SGKZNBX276G8 EIN: 821883948

SAM.gov Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Bernard Githinji AVP of Finance & Corporate Controller Auditee
Mike Milligan VICE PRESIDENT OF ACCOUNTING Auditee
Debbie Kohnle Managing Director Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
296298 2023 2024-03-21 Ernst & Young LLP $56.57M
40950 2022 2023-03-19 Ernst & Young $20.48M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
296298 2023 2024-03-21 959150 2023-002 Material Weakness Yes AB
296298 2023 2024-03-21 959149 2023-003 Material Weakness - ABL
296298 2023 2024-03-21 959148 2023-001 Material Weakness - AB
296298 2023 2024-03-21 382708 2023-002 Material Weakness Yes AB
296298 2023 2024-03-21 382707 2023-003 Material Weakness - ABL
296298 2023 2024-03-21 382706 2023-001 Material Weakness - AB
40950 2022 2023-03-19 627418 2022-001 Material Weakness - AB
40950 2022 2023-03-19 50976 2022-001 Material Weakness - AB